What are the benefits of Namenda?
Namenda (also called Memantine) was approved by the FDA in 2003 for use in people with “moderate to severe” Alzheimer’s disease or other types of dementia. The FDA rejected the manufacturer’s application to expand approval to include mild Alzheimer’s or dementia. short life online
However, the drug is often prescribed “off-label” for patients with mild Alzheimer’s or dementia even though there is little evidence of its benefit at this stage of disease and other drugs, such as Aricept and Razadyne, are more effective. “Off- label” means that the use is not on the FDA-approved label for the drug, because of lack of proof that it is safe and effective for that use.
Namenda® (memantine HCl)* has been proven to treat the symptoms of moderate to severe Alzheimer’s disease. In a clinical trial published in the New England Journal of Medicine, patients taking Namenda versus a placebo (sugar pill) experienced: 1 • A slower rate of decline in thinking over time • A significantly higher ability to perform daily activities including doing household tasks such as taking out the garbage or cleaning the table after dinner, as well as conversing 1,2 To learn more about how Namenda has been shown to help treat the symptoms of moderate to severe Alzheimer’s disease, visit Proven Benefits.
